Prevalence of and risk factors for respiratory dyskinesia

Clinical Neuropharmacology

Volumn 19, Issue 5, 1996, Pages 390-398

  Hayashi, Teruo ^a   Nishikawa, Tadashi ^b   Koga, Itsuyuki ^b   Uchida, Yasunori ^b   Yamawaki, Shigeto ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Seiwakai Nishikawa Hospital   (Japan)

Author keywords

Aging; Organic brain damage; Respiratory dyskinesia; Risk factor

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; AGING; ARTICLE; BRAIN DISEASE; BREATHING DISORDER; BREATHING PATTERN; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; MOTOR DYSFUNCTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPIROGRAPHY;

EID: 0029817366     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619050-00002     Document Type: Article

References (32)

1. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med 1978;88:327-31.
2. Yassa R, Lal S. Respiratory irregularity and tardive dyskinesia. Acta Psychiatr Scand 1986;73:506-10.
3. Nishikawa T, Kaneda W, Uegaki A, Koga I, Uchida Y, Tanaka M. Respiratory dyskinesia: a variety of clinical forms differentially diagnosed by using a spirograph. Clin Neuropharmacol 1992;15:315-21.
4. Chang E, Pitts WM Jr, Rodriguez-Garcia M. Respiratory dyskinesia: review and case reports. J Clin Psychiatry 1985;46:232-4.
5. Goswami U, Channabasavanna SM. On the lethality of the acute respiratory component of tardive dyskinesia. Clin Neurol Neurosurg 1985;87:99-102.
6. Faheem AD, Brightwell DR, Burton GC, Struss A. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia? Am J Psychiatry 1982;139:517-8.
7. Chiu H, Lam L, Chan C, Ho C, Shum P. Clinical and polygraphic characteristics of patients with respiratory dyskinesia. Br J Psychiatry 1993;162:828-30.
8. Youssef HA, Waddington JL. Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia. Int Clin Psychopharmacol 1989;4:55-9.
9. Saltz BL, Kane JM, Woerner MG, et al. Prospective study of tardive dyskinesia in the elderly. Psychopharmacol Bull 1989;25:52-6.
10. Jeste DV, Caligiuri MP. Tardive dyskinesia. Schizophr Bull 1993;19:303-15.
11. Yassa R, Nair NPV, Iskandar H, Schwartz G. Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry 1990;147:1156-63.
12. Yassa R, Nastase C, Dupont D, Thibeau M. Tardive dyskinesia in elderly psychiatric patients: a 5-year study. Am J Psychiatry 1992;149:1206-11.
13. American Psychiatric Association Task Force on Tardive Dyskinesia, ed. Tardive dyskinesia: a task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1992.
14. Samie MR, Dannenhoffer MA, Rozek S. Life-threatening tardive dyskinesia caused by metoclopramide. Mov Disord 1987;2:125-9.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, rev. Washington, DC: American Psychiatric Press, 1987.
16. Guy W, ed. ECDEU assessment manual for psychopharmacology. Publication ADM 76-338. Washington, DC: U.S. Department of Health, Education, and Welfare, 1976:534-7.
17. Schooler NR, Kane JM. Research diagnosis for tardive dyskinesia. Arch Gen Psychiatry 1982;39:486-7.
18. Yassa R, Jesie DV. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 1992;18:701-15.
19. Smith JM, Baldessarini RJ. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980;37:1368-73.
20. Lieberman J, Kane JM, Woerner M, Weinhold P. Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 1984;20:22-6.
21. Hayashi T, Yamawaki S, Nishikawa T, Jeste DV. Use and side effects of neuroleptics in elderly Japanese patients. Am J Geriatr Psychiatry 1995;3:308-16.
22. Yassa R, Nair V, Schwartz G. Tardive dyskinesia: a 2-year follow-up study. Psychosomatics 1984;25:852-5.
23. Smith JM, Kucharski LT, Oswald WT. A systematic investigation of tardive dyskinesia in inpatients. Am J Psychiatry 1979;136:918-22.
24. Smith JM, Dunn DD. Sex differences in the prevalence of severe tardive dyskinesia. Am J Psychiatry 1979;136:1080-2.
25. Richardson MA, Pass R, Craig TJ. Factors influencing the prevalence and severity of tardive dyskinesia. Psychopharmacol Bull 1984;20:33-8.
26. Kane JM, Woerner M, Lieberman L. Tardive dyskinesia: prevalence, incidence, and risk factors. In: Casey DE, Chase TN, Christensen AV, Gerlach J, eds. Dyskinesia: research and treatment. Berlin, Germany: Springer-Verlag, 1985:72-8.
27. Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-6.
28. Casey DE. Affective disorders and tardive dyskinesia. Encephale 1988;14:221-6.
29. Chiu H, Shum P, Lau J, Lam L, Lee S. Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. Am J Psychiatry 1992;149:1081-5.
30. Jackson IV, Volavka J, James B, Reker D. The respiratory components of tardive dyskinesia. Biol Psychiatry 1980;15:485-7.
31. Ingvar DH, Bulow KB. Respiratory regulation in sleep. Ann NY Acad Sci 1963;109:870-81.
32. Berger AJ, Mitchell RA, Severinghaus JW. Regulation of respiration. N Engl Med J 1977;297:92-7, 138-43, 194-201.